Back to search

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell
Small Lymphocytic Lymphoma
Clinicaltrials.gov:
EU CTIS:
#2023-504044-34-00
Other:
#54179060CLL2032
Interested in this trial?
Subscribe or share this trial
Countries:
  • Canada,
  • Czechia,
  • France,
  • Hungary,
  • Italy,
  • Poland,
  • Spain,
  • United States
Loading...
Enrolling
Milan, Italy, 20162
Enrolling
Perugia, Italy, 06132
Enrolling
Florence, Italy, 50134
Enrolling
Ferrara, Italy, 44124
Enrolling
Boise, Idaho, United States, 83702
Enrolling
Pierre-Bénite, France, 69495
Enrolling
Nantes, France, 44000
Enrolling
Reims, France, 51100
Enrolling
Los Alamitos, California, United States, 90720
Enrolling
Lublin, Poland, 20 090
Enrolling
Ogden, Utah, United States, 84405
Enrolling
Roma, Italy, 00136
Enrolling
Ostrava - Poruba, Czechia, 708 52
Enrolling
Brno-Bohunice, Czechia, 625 00
Enrolling
Hradec Králové, Czechia, 500 05
Enrolling
Prague, Czechia, 100 34
Enrolling
Olomouc, Czechia, 779 00
Enrolling
Grand Junction, Colorado, United States, 81505
Enrolling
Győr, Hungary, 9024
Enrolling
Nyack, New York, United States, 10960
Enrolling
Hinsdale, Illinois, United States, 60521
Enrolling
Paris, France, 75651
Enrolling
Córdoba, Spain, 14004
Enrolling
Barcelona, Spain, 08035
Enrolling
Santiago de Compostela, Spain, 15706
Enrolling
Madrid, Spain, 28041
Enrolling
Santander, Spain, 39008
Enrolling
Madrid, Spain, 28034
Enrolling
Flemington, New Jersey, United States, 08822
Enrolling
Iowa City, Iowa, United States, 52246
Enrolling
Orange, Florida, United States, 32763
Enrolling
Minneapolis, Minnesota, United States, 55404
Enrolling
Miami Beach, Florida, United States, 33140-2948
Enrolling
St. Catharines, Ontario, Canada, L2S 0A9
Enrolling
Vancouver, Washington, United States, 98684
Enrolling
Portland, Oregon, United States, 97239
Enrolling
Cincinnati, Ohio, United States, 45242
Enrolling
Novara, Italy, 28100
Enrolling
Milan, Italy, 20132
Enrolling
Palermo, Italy, 90146
Enrolling
Whittier, California, United States, 90602
Enrolling
Santa Rosa, California, United States, 95403
Enrolling
Halifax, Nova Scotia, Canada, B3H 1V7
Enrolling
Kansas City, Missouri, United States, 64132
Enrolling
San Luis Obispo, California, United States, 93401
Enrolling
Krakow, Poland, 30 688
Enrolling
Budapest, Hungary, 1088
Enrolling
Springfield, Illinois, United States, 62702
Enrolling
Kielce, Poland, 25 734
Enrolling
Nyíregyháza, Hungary, 4400
Enrolling
Brzozów, Poland, 36 200
Enrolling
Gdynia, Poland, 81-519
Enrolling
Fort Worth, Texas, United States, 76104
Enrolling
The Woodlands, Texas, United States, 77380
Enrolling
North Miami Beach, Florida, United States, 33169
Enrolling
Cerritos, California, United States, 90703
Enrolling
Houston, Texas, United States, 77030
Enrolling
Bari, Italy, 70124
Enrolling
Roma, Italy, 00161
Enrolling
Padua, Italy, 35129
Enrolling
Szeged, Hungary, 6725
Enrolling
Prague, Czechia, 128 00
Enrolling
Seattle, Washington, United States, 98108
Enrolling
Manassas, Virginia, United States, 20110
Enrolling
Virginia Beach, Virginia, United States, 23456
Enrolling
Eugene, Oregon, United States, 97401
Enrolling
Biała Podlaska, Poland, 21 500
Enrolling
Lodz, Poland, 93 513
Completed
Clermont-Ferrand, France, 63100
Completed
Strasbourg, France, 67200
Completed
The Woodlands, Texas, United States, 77380
Completed
Goldsboro, North Carolina, United States, 27534
Completed
Florham Park, New Jersey, United States, 07932
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials